John M. Sprague - Feb 24, 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Financial Officer
Signature
/s/ Michael Gibbs, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 24, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 04:30 PM
Previous filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +29 +25.89% 141 Feb 24, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -29 -100% $0.00* 0 Feb 24, 2024 Common Stock 29 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On February 24, 2021 the reporting person was granted 87 RSU's that vest in three equal installments commencing on February 24, 2022.